CLI Liquidating Corp  

(Public, OTCMKTS:CADMQ)   Watch this stock  
Find more results for PINK:CADMQ
May 21 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range     -
52 week     -
Open     -
Vol / Avg. 0.00/0.00
Mkt cap 71,992.00
P/E     -
Div/yield     -
EPS -0.91
Shares     -
Beta     -
Inst. own     -

Key stats and ratios

Q2 (Jun '10) 2009
Net profit margin -342.05% -579.80%
Operating margin -341.06% -582.60%
EBITD margin - -564.84%
Return on average assets -223.54% -132.63%
Return on average equity -324.41% -277.84%
Employees 78 -
CDP Score - -


47266 Benicia Street
FREMONT, CA 94538-7330
United States - Map
+1-510-3540300 (Phone)
+1-510-6574476 (Fax)


CLI Liquidating Corp, formerly Cardima, Inc., is a medical device company focused on the diagnosis and treatment of cardiac arrhythmias. Arrhythmias develop from abnormal electrical currents within the heart, and can be associated with fast, slow and/or irregular heartbeats. The arrhythmias are symptomatic, and some are associated with morbidity and even mortality. Its products have been developed for the diagnosis and treatment of the two common forms of arrhythmias, atrial fibrillation (AF) and ventricular tachycardia (VT). Its products include the PATHFINDER and REVELATION Series of diagnostic catheters, the VUEPORT and NAVIPORT Series of guiding catheters, the INTELLITEMP Energy Management Device and the Surgical Ablation System. The PATHFINDER Series of microcatheters are small, flexible wire based devices. Their design makes them the Go-To catheter for all difficult procedures when accessing and mapping in the coronary sinus.